| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 12/30/2009 | EP2138191A1 Enhanced transport using membrane disruptive agents |
| 12/30/2009 | EP2138174A1 Pharmaceutical composition in the form of a sublingual tablet consisting of a non-steroidal anti-inflammatory agent and an opiate analgesic for pain management |
| 12/30/2009 | EP2138169A2 Transdermal delivery system of hormones without penetration enhancers |
| 12/30/2009 | EP2138168A1 Agent for oral administration and method for producing the same |
| 12/30/2009 | EP2138167A1 Pharmaceutical composition comprising N-[2-(Diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene) methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide |
| 12/30/2009 | EP2138166A1 Process for production of tablet |
| 12/30/2009 | EP2138165A1 Pharmaceutical composition comprising a statin |
| 12/30/2009 | EP2138164A1 Liquid pharmaceutical formulations of docetaxel |
| 12/30/2009 | EP2138163A2 Suppository formulations comprising tenofovir or tenofovir disoproxil |
| 12/30/2009 | EP2138162A2 Gel comprising tenofovir or tenofovir disoproxil |
| 12/30/2009 | EP2138161A1 Implantable agent reservoir and device with same |
| 12/30/2009 | EP2138055A1 Formula food to be beneficial for visuognosis persistence and use thereof |
| 12/30/2009 | EP2136856A1 Coatings for implantable medical devices for liposome delivery |
| 12/30/2009 | EP2136821A2 Oral zinc medicants useful for safely lowering free copper absorption and free copper levels |
| 12/30/2009 | EP2136793A2 Tablet formulations containing 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one salts and tablets made therefrom |
| 12/30/2009 | EP2136792A1 Hot-melt micropellets |
| 12/30/2009 | EP2136791A1 Cores and microcapsules suitable for parenteral administration as well as process for their manufacture |
| 12/30/2009 | EP2136790A1 Preparation for the controlled release of bioactive natural substances |
| 12/30/2009 | EP2136789A2 Solid dosage forms comprising aliskiren and pharmaceutically acceptable salts thereof |
| 12/30/2009 | EP2136788A1 Cancer cell targeting using nanoparticles |
| 12/30/2009 | EP2136787A2 Topical formulations having enhanced bioavailability |
| 12/30/2009 | EP2136786A2 Emulsions and techniques for formation |
| 12/30/2009 | EP2136785A1 Process for dosing self-emulsifying drug delivery systems |
| 12/30/2009 | EP2136784A1 Bio-absorbable oil suspension |
| 12/30/2009 | EP2136783A2 A method of promoting muscle tissue repair |
| 12/30/2009 | EP2136782A1 Ophthalmic oil-in-water emulsions containing prostaglandins |
| 12/30/2009 | EP2136781A1 Mucosal bioadhesive slow release carrier for delivering active principles |
| 12/30/2009 | EP2136780A1 Use of ranolazine for the treatment of cardiovascular diseases |
| 12/30/2009 | EP2136751A1 Method for supplying oxygenated water to promote internal healing |
| 12/30/2009 | EP2136648A1 Center-filled chewing gum product for dental care |
| 12/30/2009 | EP1928427B1 Novel dosage formulation |
| 12/30/2009 | EP1738026B1 Paper tissue with high lotion transferability |
| 12/30/2009 | EP1727532B1 Chemically stable compositions of 4-hydroxy tamoxifen |
| 12/30/2009 | EP1701701B1 Methods of preparing a foam comprising a sclerosing agent |
| 12/30/2009 | EP1689426B1 Pharmaceutical formulations for the sustained release of interferons and therapeutic applications thereof |
| 12/30/2009 | EP1532149B1 8-[3-amino-piperidin-1-yl]-xanthines, the production thereof and the use of the same as medicaments |
| 12/30/2009 | EP1504037B1 Ferritin fusion proteins for use in vaccines and other applications |
| 12/30/2009 | EP1501498B1 Pharmaceutical composition comprising a lipase inhibitor and glucomannan |
| 12/30/2009 | EP1397123B1 Delivery of small hydrophilic molecules packaged into lipid vesicles |
| 12/30/2009 | EP1309327B1 Pharmaceutical compositions of estrogenic agents |
| 12/30/2009 | EP1242012B1 Improved transdermal contraceptive delivery system and process |
| 12/30/2009 | EP1126882B1 Stable preparations with hyperforin |
| 12/30/2009 | EP0863754B2 Hydrolysis-optimized lipid emulsions and use thereof |
| 12/30/2009 | CN201373827Y Tablet hardness detector |
| 12/30/2009 | CN101616660A High dose film compositions and methods of preparation |
| 12/30/2009 | CN101613321A Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage |
| 12/30/2009 | CN101612141A Buprenorphine patch |
| 12/30/2009 | CN101612140A Preparation method of diclofenac potassium sustained-release pellet capsule |
| 12/30/2009 | CN101612139A Thermal initiation spontaneous explosion type magnetically targeted micro-capsule and preparation method thereof |
| 12/30/2009 | CN101612138A Cefetamet pivoxil hydrochloride capsule and preparation method thereof |
| 12/30/2009 | CN101612137A Cilostazol capsule and preparation method thereof |
| 12/30/2009 | CN101612136A Chinese medicinal tablet thin film coating material and method for preparing same |
| 12/30/2009 | CN101612135A Levetiracetam composition for direct tabletting and preparation method thereof |
| 12/30/2009 | CN101612134A Isoconeazole nitrate vagina tablet and preparation method thereof |
| 12/30/2009 | CN101612133A Nateglinide tablet and preparation method thereof |
| 12/30/2009 | CN101612132A Chondroitin sulfate slow-release tablet and preparation method thereof |
| 12/30/2009 | CN101612131A 2-methoxyestradiol nanosuspension frozen powder and preparation method thereof |
| 12/30/2009 | CN101612130A Preparation technique of low molecular weight sodium heparin used for injection |
| 12/30/2009 | CN101612129A Nicotinylmethylamide freeze-dried powder preparation for injection and preparation method thereof |
| 12/30/2009 | CN101612128A Alginic acid inorganic nanometer composite gel microspheres and preparation method |
| 12/30/2009 | CN101612127A Preparation method of implantable slow-release medicament millimeter particle |
| 12/30/2009 | CN101612126A Preparation of immunoliposome of CD19 monoclonal antibody and application |
| 12/30/2009 | CN101612125A Immunosuppression effect of paclitaxel liposome and therapeutic effect thereof on rheumatoid arthritis |
| 12/30/2009 | CN101612124A Lipoid plasmid and preparation method of formulation thereof |
| 12/30/2009 | CN101612123A Preparation method and use of pyritinol and liposome of salt of pyritinol |
| 12/30/2009 | CN101612122A Atomization immunization method of pig attenuated vaccines |
| 12/30/2009 | CN101612121A Preparation method of yew alcohol micro-emulsion |
| 12/30/2009 | CN101612120A Fleroxacin freeze-dry emulsion and production method thereof |
| 12/30/2009 | CN101612119A Cucurbitacin solid lipid nanoparticle preparation and preparation method thereof |
| 12/30/2009 | CN101612118A Porcine compound astragalus polysaccharide injection and preparation method thereof |
| 12/30/2009 | CN101612117A Compound concentrated sodium chloride injection for animals and preparation method thereof |
| 12/30/2009 | CN101612116A Compound vitamin B1 injection for treating domestic animals dyspepsia and preparation method thereof |
| 12/30/2009 | CN101612115A Compound difluprednate ointment |
| 12/30/2009 | CN101612114A Recombinant human interferon a2b suppository and preparation method thereof |
| 12/30/2009 | CN101612113A Nerve growth factor sponginum and preparation method thereof |
| 12/30/2009 | CN101612112A Gelatinous ungluing agent used on surface of organism and application thereof |
| 12/30/2009 | CN101612111A Sustained-release microsphere of nomegestrol acetate of analogs thereof and preparation method and application thereof |
| 12/30/2009 | CN101612110A Triacetyluridine slow-release preparation and preparation method thereof |
| 12/30/2009 | CN100575945C A detection method for coronary heart disease treating medicine tablet of seven ingredients |
| 12/30/2009 | CN100574862C Encapsulated materials |
| 12/30/2009 | CN100574807C Tree plant oil women's medical sanitary tampon and method of preparing the same |
| 12/30/2009 | CN100574806C Biodegradable triblock copolymers as solubilizing agents for drugs and method of use thereof |
| 12/30/2009 | CN100574800C Proprietary Chinese medicine for treating atherosclerosis of cardio-cerebral arteria and method for preparing the same |
| 12/30/2009 | CN100574799C Ginseng sini injection four treating cold limbs and preparing method |
| 12/30/2009 | CN100574797C Plaster for treating osteopathy |
| 12/30/2009 | CN100574796C Medicine for treating heart disease and preparation process thereof |
| 12/30/2009 | CN100574795C Chinese traditional medicine for treating myocarditis |
| 12/30/2009 | CN100574794C Traditional Chinese medicine composition for delaying skin senility |
| 12/30/2009 | CN100574792C Chinese medicine composition effective ingredient detection method |
| 12/30/2009 | CN100574790C Medicine composition for preventing and treating peptic ulcer |
| 12/30/2009 | CN100574789C External Chinese traditional medicine for accelerating wound healing, reducing cicatrisation, and preparation method |
| 12/30/2009 | CN100574785C Compound Chinese traditional medicine for treating neuropathic pain |
| 12/30/2009 | CN100574784C Orally taken traditional Chinese medicine composition for treating bacillary dysentery |
| 12/30/2009 | CN100574782C Application of aqueous solution containing nicotine in preparing medicine for quit smoking |
| 12/30/2009 | CN100574781C Animal medicine for treating gout, its preparation method and use |
| 12/30/2009 | CN100574780C Compositions against inflammatory processes |
| 12/30/2009 | CN100574776C Outer applying liquid for treating burn and scald, and preparation method |
| 12/30/2009 | CN100574774C 'Mikang' gels of Chinese traditional medicine for curing inflammation of cervical erosion and preparation method |
| 12/30/2009 | CN100574772C Soft capsule containing lutein and its preparation method |
| 12/30/2009 | CN100574771C Medicine for treating women's genital system disease |